Hepatitis B immunoprophylaxis failure and the presence of hepatitis B surface gene mutants in the affected children. Issue 8 (17th March 2015)

• Record Type: Journal Article
• Authors: Lee, Le Ye; Aw, Marion; Rauff, Mary; Loh, Kah‐Sin; Lim, Seng Gee; Lee, Guan Huei
• Is Part Of: Journal of medical virology. Volume 87:Issue 8(2015:Aug.)
• Page Start: 1344
• Page End: 1350
• Publication Date: 2015-03-17
• Subjects: Virology -- Periodicals; 616
• DOI: 10.1002/jmv.24193
• Languages: English
• ISSNs: 0146-6615

Abstract

<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jmv24193-sec-0001" sec-type="section"> <p>Hepatitis B virus (HBV) infection is usually vertically transmitted from the mother to child during birth in Asian countries. Despite immunization, immunoprophylaxis failure is well‐documented. The aim of the study was to study immunoprophylaxis failure rate in the cohort of infants delivered by chronic HBV‐infected mothers and to determine risk factors for failure. This was an observational study involving chronic hepatitis B infected mothers seen at a tertiary care center in Singapore between June 2009 and December 2013. Infants born to these mothers were recruited after they had completed the recommended vaccination schedule. Serological testing for the children was performed 3 months after completion of the last dose of vaccine. HBV surface gene sequencing was carried out if HBV DNA was detectable in the children. Among the 161 mothers enrolled, most were HBeAg negative. HBeAg positive mothers were younger and had a significantly higher viral load (6.5 log) as compared to HBeAg negative mothers (1.35 log) (<italic>P</italic> < 0.001). Four children (2.6%) were found to have immunoprophylaxis failure. Two occurred in children delivered by mothers with extremely high viral load of more than 5 × 10<sup>7</sup> IU/ml. HBV surface gene mutations were detected in most children (3 out of 4) with immunoprophylaxis failure. The overall effectiveness of the hepatitis B vaccination program was high. High maternal viral load and presence of surface gene mutants may be potential contributors. <bold><italic>J. Med. Virol. 87:1344–1350, 2015</italic>.</bold> © 2015 Wiley Periodicals, Inc.</p> </sec> </abstract>